Healthcare startup Nolla Health has announced a new pilot program in Utah that allows users to obtain acne prescriptions through an AI system, marking a shift toward autonomous medical decision-making for routine conditions.
What Happened
On Monday, Nolla Health revealed that residents in Utah can use its app to scan their faces, enabling an AI system to analyze acne severity and autonomously write a prescription. The service launches with a phased approach to physician oversight: for the first 100 patients, two physicians will approve every AI-generated prescription before it is issued. After the initial cohort, physicians will review prescriptions only after they have been issued for up to 500 patients. Nolla Health states that beyond this point, doctors will review a sample of at least 10% of prescriptions monthly, along with every case involving an escalation or side effect.
The program is priced at $4.99 per month and is restricted to Utah residents aged 18 and older who have mild-to-moderate acne. The AI system is capable of prescribing eight different skin treatments. If the AI cannot "confidently select a treatment," the startup directs users to a physician.
Why It Matters
While other healthcare companies in Utah are experimenting with AI for medication renewals following state regulatory changes earlier this year, Nolla Health claims it is the first in the country to issue initial prescriptions via AI rather than just renewals. The company positions the tool as a complement to, rather than a replacement for, human doctors. By handling routine, low-acuity cases, Nolla Derm aims to free dermatologists to focus on complex, high-risk patients, potentially addressing provider shortages in dermatology.
The Bottom Line
Nolla Health’s pilot represents a significant test case for autonomous AI in healthcare, moving beyond administrative renewals to initial diagnostic and prescribing decisions, albeit with strict human oversight safeguards in place during the transition.